# Biokit USA, Inc.

- Location (FDA's records): Barcelona, ES
- FDA decisions: 16 (1984–1993): 16 510(k) clearances
- Product codes: GTQ (4), DHR (3), DCN (2), LQN (2), GMQ (1), KTN (1), LLA (1), DCK (1), GMP (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 5 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Instrumentation Laboratory CO: 5 (https://510kreport.com/company/instrumentation-laboratory)

## Its most-cited devices
- K896271: Quantex RF Plus (Latex, Buffer Standard, Control) (1989), cited by 2
- K894486: Quantex Aso Plus (Latex,Buffer Standard,Control) (1989), cited by 1
- K896272: Quantex CRP Plus (Latex, Buffer, Standard, Control (1989), cited by 1
- K913467: Toxogen (1993), cited by 1

## Recent decisions
- K913467: Toxogen (Jan 11, 1993)
- K910541: Biokit RPR (Oct 18, 1991)
- K904310: Rheumagen RF T-Control (May 31, 1991)
- K910539: Rheumajet RF (Apr 5, 1991)
- K910686: Rheumajet CRP (Mar 19, 1991)
- K904311: Rheumagen Aso T-Control (Jan 25, 1991)
- K904312: Rheumagen CRP T-Control (Oct 1, 1990)
- K896433: Modified Rubagen (Nov 29, 1989)

Source page: https://510kreport.com/company/biokit-usa